
CCR5 antagonists inhibit HIV-1 entry by blocking the interaction of HIV-1 with the CCR5 cellular receptor. In patients with established HIV-1 infection, some viral strains use an alternative coreceptor for HIV-1 entry, CXCR4; CCR5 antagonists are not effective in patients harboring these viral strains. Coreceptor tropism testing of viral strains in an individual patient is necessary prior to treat...
File Size: 1323 KB
Print Length: 23 pages
Simultaneous Device Usage: Unlimited
Publisher: Annual Reviews (December 12, 2012)
Publication Date: December 12, 2012
Sold by: Amazon Digital Services LLC
Language: English
ASIN: B00ANNHCI2
Text-to-Speech: ::::
X-Ray:
Word Wise: Not Enabled
Lending: Not Enabled
Format: PDF ePub fb2 TXT fb2 ebook
- Timothy J. Wilkin epub
- Timothy J. Wilkin books
- Annual Reviews (December 12, 2012) epub
- Medical Books epub ebooks
- December 12, 2012 pdf
Here The celestial caé pdf link Gangster girl saga Download Kauai trailblazer where to hike snorkel bike paddle surf pdf at allsipakuging.wordpress.com Soulul souns accomaniment tracks Download Flight of the dodo pdf at compballeti.wordpress.com Download Mountains o maness pdf at anngere.wordpress.com Hunted whiteout white out Here Alberti on ainting pdf link Download Endgame strategy cadogan chess books pdf at duparnenmai.wordpress.com
CCR5 antagonist. There is one CCR5 antagonist, maraviroc, that is FDA-approved for treatment of HIV-1 infection. This drug is used most commonly for the treatment of HIV-1 infection in patients who have failed other antiretroviral regimens. In addition to virologic effects, CCR5 antagonists are under investigation for immune-modulating effects and for HIV-1 prevention. Ongoing research will further elucidate the role of CCR5 antagonists in combating HIV disease.